Production (Stage)
Applied Therapeutics, Inc.
APLT
$0.4099
-$0.0001-0.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -149.59% | 164.16% | -2,466.84% | 103.45% | -122.77% |
| Total Depreciation and Amortization | 30.00% | -23.08% | -14.75% | 1.67% | 1,900.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 97.52% | -263.72% | 302.74% | -131.50% | 248.24% |
| Change in Net Operating Assets | -194.86% | 83.69% | 162.03% | -323.39% | -166.76% |
| Cash from Operations | -47.09% | 16.55% | -3.25% | -19.48% | -11.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 33.12% |
| Issuance of Common Stock | -- | -- | -- | -- | 287.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 100.00% | -101.46% | 292.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.09% | 16.55% | 3.94% | -125.15% | 676.35% |